(Q44695275)

5 December 2017

title

The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis (English)

1 reference

5 December 2017

Weilbach FX

1

1 reference

5 December 2017

Chan A

series ordinal

2

1 reference

5 December 2017

Toyka KV

series ordinal

3

1 reference

5 December 2017

Gold R

series ordinal

4

1 reference

5 December 2017

publication date

1 January 2004

1 reference

Clinical and Experimental Immunology

5 December 2017

published in

1 reference

5 December 2017

volume

135

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

49-55

1 reference

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02344.X

Suppression of demyelination by mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02344.X

Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02344.X

Iron chelators induce apoptosis in proliferating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02344.X

In vitro effects of three iron chelators on mitogen-activated lymphocytes: identification of differences in their mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02344.X

Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02344.X

Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02344.X

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

Suppression of experimental allergic encephalomyelitis by mitoxantrone.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent: elucidation by the action of mitoxantrone

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808927

In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat

27 August 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2004.02344.X

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function

21 January 2018

1 reference

12 December 2020

Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone

1 reference

12 December 2020

Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques

1 reference

12 December 2020

Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases

1 reference

12 December 2020

10.1111/J.1365-2249.2004.02344.X

Identifiers

DOI

1 reference

5 December 2017

0 references

1 reference